The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. grew its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 41.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 344,643 shares of the medical device company's stock after purchasing an additional 101,494 shares during the period. D. E. Shaw & Co. Inc. owned approximately 0.17% of Cooper Companies worth $31,683,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in COO. Fulton Bank N.A. grew its holdings in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock worth $342,000 after purchasing an additional 109 shares during the last quarter. Covestor Ltd grew its holdings in shares of Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares during the last quarter. Torray Investment Partners LLC grew its holdings in shares of Cooper Companies by 0.8% during the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock worth $1,488,000 after purchasing an additional 132 shares during the last quarter. Mather Group LLC. grew its holdings in shares of Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock worth $177,000 after purchasing an additional 133 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB grew its holdings in shares of Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after purchasing an additional 136 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

COO traded down $2.68 during trading on Tuesday, reaching $81.76. The company's stock had a trading volume of 1,568,444 shares, compared to its average volume of 1,450,892. The Cooper Companies, Inc. has a 52-week low of $69.81 and a 52-week high of $112.38. The company's fifty day moving average price is $80.22 and its 200-day moving average price is $90.59. The company has a market capitalization of $16.35 billion, a price-to-earnings ratio of 41.93, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on COO shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird dropped their price objective on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. Stifel Nicolaus dropped their price objective on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Piper Sandler reaffirmed an "overweight" rating and set a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Finally, Citigroup dropped their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.